Overall, we performed a systematic evaluation of the underlying regulatory mechanisms of IGF2BP3 and its effects on prognosis, the infiltration of immune cells, the levels of CNV, and therapeutic sensitivity in melanoma. The gene discussed is IGF2BP3; the disease is melanoma.